Acute asthma
Definitions in acute asthma
NICE guidance advises that acute asthma attacks be graded by severity using criteria such as peak flow, observations such as heart rate and respiratory rate, ABG (arterial blood gas) results and clinical symptoms.
Patients presenting with severe or life-threatening asthma attacks should be started on asthma treatment immediately and should be treated in secondary care facilities. Patients with moderate asthma attacks can be trialled on treatment at home or in primary care, in the first instance.
| Moderate | Acute severe | Life threatening | Near fatal |
|---|---|---|---|
| Increasing symptoms
PEF 50-75% best or predicted No features of acute severe asthma |
PEF 33-50% best or predicted
RR ≥25 /min HR ≥110 bpm Inability to complete sentences in one breath |
PEF <33% of predicted
PaO2 <8 kPA Normal PaCO2 (4.6-6.0) Exhaustion, altered consciousness Arrhythmia Hypotension Cyanosis Poor respiratory effort, silent chest |
Raised PaCO2
Requiring mechanical ventilation with raised inflation pressures |
Table 2 Grading of acute asthma
Investigations in acute asthma
These should include:
- ABG if saturations <92% or with other features of life-threatening asthma
- Chest X-ray if there is any suspicion of consolidation, pneumothorax, any features of life-threatening asthma or if the patient is not responding to initial treatment
Management of acute asthma
General management includes:
- Oxygen to keep saturations 94-98%
- Corticosteroids: prednisolone 40 mg for a minimum of 5 days; ICS should be continued during this time
- Salbutamol (SABA): the nebulised route (2.5-5 mg) is preferred if there are any features of acute severe asthma; IV is reserved for those in whom inhaled routes are unreliable, e.g. with altered consciousness
- Ipratropium bromide (short-acting muscarinic antagonist): nebulised; if no response to above treatments
- IV magnesium sulphate if features of acute severe asthma are present
Intensive care referral should be considered with any of the following:
- Ventilatory support is required
- Acute severe or life-threatening asthma failing to respond to therapy, as evidenced by:
- Investigations: deteriorating PEF, persistent or worsening hypoxia, hypercapnia, worsening acidosis
- Clinical features: exhaustion, drowsiness, altered conscious state, respiratory arrest
Criteria for discharge
Prior to discharge, a patient should be stable off nebulisers and oxygen for 12-24 hours, have a peak flow >75% of predicted or best, and have had their inhaler technique checked.
Take your subscriptions with you
Our mobile app allows you to access your interview and exam question banks wherever you are.